NEW YORK (AP) — NEW YORK (AP) — Actinium Pharmaceuticals Inc. (ATNM) on Monday reported a loss of $11 million in its first quarter.
The New York-based company said it had a loss of 43 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.
Actinium shares have decreased 21% since the beginning of the year. The stock has climbed 46% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNM at https://www.zacks.com/ap/ATNM
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
